|
Startup News and Information for Silicon Valley |
|
Friday, November 20, 2009 Trivascular Snags $30MSanta Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates, Delphi Ventures, MPM Capital, and Kearny Venture Partners, all existing investors in the firm. The company said the new funding round will go towards its operations and infrastructure. posted on Friday, November 20, 2009 (Link to more information)
|
Previous Issues Tuesday, February 9, 2010 Monday, February 8, 2010 Friday, February 5, 2010 Thursday, February 4, 2010 Wednesday, February 3, 2010 |